Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes.
AMA J Ethics. 2022;24(2):E111-119. doi:
10.1001/amajethics.2022.111.
Dr Matthew K. Wynia joins Ethics Talk to discuss his article, coauthored with Dr Robert Baker: “Living Histories of Structural Racism and Organized Medicine”
Critical race theory tools of evaluating stock characters and counter stories can help clinicians and researchers illuminate experiences of those at the margins.
AMA J Ethics. 2022;24(3):E212-217. doi:
10.1001/amajethics.2022.212.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
In the 1910s, the American Medical Association fought quackery promoted in pamphlets for drugs and treatments for everything from teething to epilepsy.
AMA J Ethics. 2018;20(11):E1082-1093. doi:
10.1001/amajethics.2018.1082.